The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

Join Troutman Pepper Locke Partners Karlie Webb and Ben Cowan as they delve into the complexities of the Inflation Reduction ...

Democrats held unified control of government for two years under President Joe Biden. They spent their political capital to ...

CHARLESTON — West Virginia officials are in contact with the administration of President Donald Trump after an executive ...

President Trump signed an executive order entitled “Unleashing American Energy” (the Executive Order) aimed at reversing many ...

In his first day in office, President Donald Trump initiated a 90-day review of aspects of the Inflation Reduction Act and the Infrastructure Investment ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

Panelists discuss how the inclusion of ibrutinib on the Inflation Reduction Act (IRA) negotiated drug price list could make it a more economically attractive first-line option, potentially influencing ...